Sign In
Buy IRIX
$1.18
+0 (+0%)
At Close: Jun 23, 2026
Iridex to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021
04:05pm, Monday, 08'th Mar 2021
MOUNTAIN VIEW, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
IRIX Stock Price Increases Over 20% Pre-Market: Why It Happened
07:40am, Wednesday, 03'rd Mar 2021
The stock price of IRIDEX Corporation (NASDAQ: IRIX) is trading at over 20% pre-market. This is why it happened.
Iridex Announces Strategic Collaboration with Topcon Corporation
04:05pm, Tuesday, 02'nd Mar 2021
MOUNTAIN VIEW, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
IRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2020
04:05pm, Monday, 11'th Jan 2021
MOUNTAIN VIEW, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year e
Iridex To Benefit From New Revolutionary Glaucoma Treatment
09:28am, Monday, 11'th Jan 2021
Iridex Corp. seems to be at the initial stage of a growth inflection that could drive the stock up 175-625%. IRIX has a commercial product which could revolutionize glaucoma treatment, with an address
IRIDEX Announces MicroPulse Transscleral Laser Therapy Now Accepted in the European Glaucoma Society Guidelines
04:05pm, Tuesday, 22'nd Dec 2020
MOUNTAIN VIEW, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal d
IRIDEX's (IRIX) CEO Dave Bruce on Q3 2020 Results - Earnings Call Transcript
10:17pm, Monday, 09'th Nov 2020
IRIDEX's (IRIX) CEO Dave Bruce on Q3 2020 Results - Earnings Call Transcript
IRIDEX Announces Third Quarter 2020 Financial Results
04:05pm, Monday, 09'th Nov 2020
MOUNTAIN VIEW, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 26, 2020.
Earnings Outlook For Iridex
10:19am, Friday, 06'th Nov 2020
Iridex (NASDAQ: IRIX) unveils its next round of earnings this Monday, November 09. Get prepared with Benzinga's ultimate preview for Iridex's Q3 earnings.
IRIDEX to Present at the 2020 Stifel Virtual Healthcare Conference
04:05pm, Tuesday, 03'rd Nov 2020
MOUNTAIN VIEW, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Virtual Healthcare Conference.
Nevakar Inc. (“Nevakar”), a privately held, late-stage, biopharmaceutical company developing multiple innovative medications in the ophthalmic and hos
Aradigm (OTCMKTS:ARDMQ) & IRIDEX (OTCMKTS:IRIX) Financial Contrast
01:34am, Saturday, 17'th Oct 2020
Aradigm (OTCMKTS:ARDMQ) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst
Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?
06:53pm, Wednesday, 19'th Aug 2020
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Global Energy-Based Aesthetic Devices Market Report 2020-2024 - ResearchAndMarkets.com
12:00am, Tuesday, 11'th Aug 2020
The
The Global Glaucoma Surgery Devices Market will grow by USD 1.53 bn during 2020-2024
